Exhibiting a Y-o-Y growth of 5.4%, the global aortic endograft market size is expected to reach US$ 3,430.3 million in 2024. Over the forecast period, global demand for aortic endografts is poised to grow at 4.9% CAGR. By 2034, the global aortic endograft revenue is projected to total US$ 5,513.5 million.
| Attribute | Details |
|---|---|
| Base Market Value (2023) | US$ 3,255.5 million |
| Estimated Aortic Endograft Market Value (2024) | US$ 3,430.3 million |
| Projected Market Size (2034) | US$ 5,513.5 million |
| Value CAGR (2024 to 2034) | 4.9% |
Growing prevalence of aortic aneurysms is emerging as a prominent factor driving growth of the aortic endograft market. This is because aortic endografts are often used for treating aortic aneurysms.
Rising adoption of medical treatments like endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm (AAA) and other conditions will likely fuel aortic endograft demand. Similarly, increasing health awareness is set to foster market growth.
Open surgery is the standard therapy for aortic stenosis, in which an abdominal incision is made, and a synthetic aortic graft is used to replace the damaged segment of the aorta. On the other hand, EVAR is a less intrusive alternative. Growing need for these procedures due to high prevalence of aortic stenosis and aortic aneurysms is expected to create prospects for the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Aortic Endograft Market Trends
Global sales of aortic endografts recorded a historic CAGR of 3.6% from 2019 to 2023. The market value for the aortic endograft market was around 5.9% of the global cardiovascular devices market, valued at US$ 53,020.7 million.
In the assessment period, the worldwide aortic endograft market is set to grow at 4.9% CAGR. It will likely attain a valuation of US$ 5,513.5 million by the end of 2034.
| Historical CAGR (2019 to 2023) | 3.6% |
|---|---|
| Forecast CAGR (2024 to 2034) | 4.9% |
The increasing aging population globally has brought about a surge in the prevalence of aortic diseases, particularly abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA). As individuals age, the risk of developing such conditions rises, leading to a growing demand for advanced medical interventions requiring aortic endografts.
Endovascular surgeries have emerged as a significant driver for the aortic endograft market. The world is witnessing a notable demographic shift, with a substantial increase in the aging population. The global population aged 60 and older is expected to double by 2050, reaching nearly 2.1 billion, according to the World Health Organization (WHO).
Aging is a major risk factor for aortic diseases, including aneurysms, which are characterized by the abnormal dilation of the aorta. This is expected to play a key role in driving demand for aortic endografts during the assessment period.
Endovascular surgeries like EVAR have gained prominence as a less invasive alternative to traditional open surgeries for treating aortic diseases. Endovascular aneurysm repair (EVAR) involves the insertion of a stent graft (aortic endograft) through small incisions in the groin, reducing the need for extensive surgical intervention. This approach offers several advantages, including quicker recovery times, reduced postoperative complications, and shorter hospital stays.
The aortic endograft market is poised for continued expansion, fueled by the aging demographic and increasing awareness about minimally invasive treatment options. The ongoing research and development activities aim to enhance the efficacy and safety of endovascular procedures. This will contribute to the market's evolution.
Principal Consultant
Asia Pacific's emerging nations, including China and India, are hotspots for investment potential for aortic endograft manufacturers. This is because of their modern healthcare systems, increased collaborations, and faster growth rates in endovascular diagnostics.
Developing economies often experience an increase in the prevalence of lifestyle-related diseases, such as cardiovascular conditions, including aortic aneurysms. The growing burden of aortic diseases creates a demand for effective and advanced treatment options, driving the acceptance of aortic stent grafting systems.
Economic growth in developing economies often leads to rising affluence among the population. As individuals experience higher disposable incomes, there is an increased capacity for healthcare spending. This financial uplift contributes to the acceptance of advanced medical treatments, including aortic endograft procedures.
Improving economic conditions also coincides with increased health insurance penetration in developing economies. As more individuals gain access to insurance coverage, the financial barriers to accessing advanced medical interventions are mitigated, fostering greater acceptance.
To increase revenue share, medical device manufacturing companies are focusing on developing novel aortic stent grafts, such as abdominal aortic stent grafts and thoracic aortic stent grafts. This will bode well for the aortic endograft market.
Increasing demand for aortic stent grafts from end users, such as hospitals and ambulatory surgical centers, for better output and performance will generate opportunities for companies. To capitalize on this, key players are expected to launch novel aortic stent graft products in the market over the long run.
The increasing acceptance of aortic stent grafting systems in developing economies is expected to continue shaping the future landscape of the aortic endograft market. As these regions experience further economic development, demand for advanced medical treatments and aortic endograft procedures is likely to rise.
Product recall is a significant restraint in the aortic endograft market, and instances like the one involving Cook Medical exemplify the impact of such events in the market. A product recall not only affects the financial standing of manufacturers but also erodes the trust of healthcare professionals and patients, posing challenges to the market's overall growth.
An illustrative example of the impact of product recall is Cook Medical's recall of its thoracic endovascular graft, specifically related to the correction for use in blunt thoracic aortic injury. This recall had consequences for the overall market.
Cook Medical initiated a correction for use, which essentially removed indications for blunt thoracic aortic injury. The correction affected the availability of specific sizes of thoracic endovascular grafts in the market.
The recall had direct implications for the aortic endograft market, particularly in North America. The removal of specific sizes from the market limited the options available for healthcare professionals, potentially affecting patient treatment strategies.
Manufacturers need to implement stringent quality assurance measures to minimize the risk of product defects and recalls. Investing in robust quality control protocols can prevent issues before they reach the market.
The financial implications, loss of credibility, and market share erosion underscore the challenges that manufacturers face. Moving forward, the industry must prioritize quality assurance, regulatory compliance, and transparent communication to navigate and mitigate the impact of product recalls on the aortic endograft market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
This section highlights the aortic endograft market across prominent countries. China and India are predicted to register higher CAGRs of 10.3% and 10.6%, respectively, through 2034. Information provided in this section can help aortic endograft companies expand their presence in nations that can provide lucrative revenue-generation opportunities.
Market Growth Outlook by Key Countries
| Country | Value CAGR |
|---|---|
| United States | 2.7% |
| Germany | 3.2% |
| United Kingdom | 2.4% |
| Japan | 5.9% |
| China | 10.3% |
| India | 10.6% |
The United States dominates the global market for aortic endografts, and the trend is expected to continue through 2034. This is due to growing incidence of aortic aneurysms and other diseases, availability of innovative aortic stent grafts, and adoption of advanced aneurysm treatment technologies.
As per the latest report, the United States aortic endograft market size is poised to reach US$ 1,231.9 million in 2033. Over the forecast period, demand for aortic endografts in the United States will likely grow at 2.7% CAGR.
The incidence of aortic aneurysms and associated disorders has increased significantly during the last few years. For instance, as per the Centers for Disease Control and Prevention (CDC), around 9,904 people in the United States died due to aortic aneurysm or aortic dissections in 2019. This is expected to create a conducive environment for the aortic endograft industry.
Another key factor expected to boost the United States aortic endograft share is the growing popularity of minimally invasive procedures. When compared to open surgery, minimally invasive techniques frequently yield quicker recovery periods, less discomfort, and lower morbidity.
China aortic endograft market is poised to register a robust CAGR of 10.3% during the forecast period. Overall sales of aortic endografts in China are estimated to be valued at US$ 422.3 million in 2033.
The need for aortic endografts is driven by China's growing aging population, which increases the prevalence of aortic illnesses and aneurysms. Aortic endograft demand as a less invasive substitute for conventional surgical treatments is also increasing due to rising awareness of aortic illnesses and the availability of cutting-edge treatment alternatives.
Modern aortic endograft technologies are adopted because of China's dedication to technological breakthroughs in the medical profession. It is drawing in both domestic and foreign producers due to lax government regulations and robust technological growth.
Growing need for endovascular aneurysm repair and high adoption of advanced aortic endograft systems will further boost China market. Subsequently, continuous aneurysm treatment advancements are expected to expand China’s aortic stent graft market size.
India is anticipated to emerge as one of the most lucrative markets for aortic endograft manufacturers during the forecast period. This is due to rising cases of aortic disorders, growing health awareness, and favorable government support. As per the latest report, India aortic endograft market is set to advance with an impressive CAGR of 10.6% through 2034.
In India, aging populations are frequently linked to aortic disorders, such as thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA). The need for aortic endografts may increase as the population ages and the incidence of these illnesses rises.
Technological developments in aortic endografts, including better delivery systems, materials, and designs, can increase operation safety and efficacy. Newer technologies may be more likely to be adopted by surgeons and healthcare providers, which would accelerate market expansion.
Greater public and healthcare professional knowledge about aortic disorders and available treatments may aid premature detection and action. Increased demand for aortic endografts may result from increased case identification brought about by improved diagnostic capabilities.
The below section provides profound insights into leading segments and their respective shares in the aortic endograft market. This information can help companies to invest in demanding products and find the most profitable end users for their business.
Market Growth Outlook by Key Products
| Product | Value CAGR |
|---|---|
| Abdominal Aortic Grafts | 4.8% |
| Thoracic Aortic Grafts | 7.2% |
Abdominal aortic grafts are expected to retain their dominance in the global endovascular device industry during the forecast period. As per the latest analysis, sales of abdominal aortic grafts will likely rise at 4.8% CAGR through 2034.
The target segment is set to account for a revenue share of 86.8% in 2024. This is attributable to rising prevalence of abdominal aortic aneurysms (AAA) and growing need for treating this health condition globally.
Abdominal aortic endografts have become life-saving solutions for patients suffering from AAA. These medical devices are used to replace a damaged or weakened section of the abdominal aorta.
Increasing incidence of AAA globally is expected to elevate abdominal aortic endograft demand through 2034. Similarly, rising popularity of minimally invasive procedures will further boost the target segment.
Minimally invasive methods, such as endovascular surgery, which requires fewer incisions than open surgery, are frequently used to implant abdominal aortic grafts. This less invasive method can lead to quicker recuperation periods, shorter hospital stays, and less money spent on medical treatment overall.
When compared to open surgical repair, minimally invasive methods involving abdominal aortic grafts are linked to decreased rates of morbidity and mortality. They are, therefore, a better option, particularly for those who, because of their age or other medical issues, could be deemed too risky for standard surgery.
Market Growth Outlook by Key Material
| Materials | Value CAGR |
|---|---|
| Metallic Endografts | 4.8% |
| Polymeric Endografts | 5.3% |
As per the latest aortic endograft industry analysis, polymeric endografts are set to witness a higher demand in the market. This can be attributed to their flexibility and reduced risk of complications.
Polymeric materials are generally more pliable and conformable than metallic materials. This flexibility makes it possible to handle complicated and anatomically difficult cases by facilitating easier navigation through twisted anatomy.
Polymeric aortic endografts can be more discreet than their metallic counterparts. This reduced profile makes minimally invasive operations easier and helps deliver and install the endograft through vessels with a smaller diameter.
The lower thrombogenicity of polymeric endografts is another key factor increasing their popularity. This improves the graft's long-term patency and lowers the chance of blood clot development.
The polymeric endografts segment is anticipated to total US$ 2,188.9 million in 2024. Over the assessment period, demand for polymeric endografts will likely rise at 5.3% CAGR. To benefit from this, key aortic endograft manufacturers will look to upgrade their polymeric endograft portfolios.
Market Growth Outlook by Key Procedure
| Procedure | Value CAGR |
|---|---|
| Open Surgical Repair | 4.5% |
| Endovascular Aneurysm Repair (EVAR) | 5.5% |
Based on procedure, the endovascular aneurysm repair (EVAR) segment is expected to lead the aortic endograft market through 2034. It will likely advance with a CAGR of 5.5% throughout the forecast period. This is due to growing preference for minimally invasive procedures for treating aortic aneurysms.
EVAR is a less invasive method of treating aortic aneurysms than open surgery. Rather than creating a huge belly incision, this less invasive method usually entails making minor incisions in the groin area to access the blood arteries.
Compared to open surgical treatments, patients opting for EVAR typically have shorter hospital stays and faster recovery durations. They can resume regular activities sooner, thanks to EVAR's minimally invasive nature.
Research indicates that endoscopic vein grafting (EVAR) is linked to reduced mortality rates when contrasted with open surgical repair, especially in individuals who are deemed more susceptible to problems. Hence, the target segment will play a key role in molding growth of the aortic endograft market over the forecast period.
Market Growth Outlook by Key End User
| End User | Value CAGR |
|---|---|
| Hospitals | 4.4% |
| Ambulatory Surgical Centers | 6.0% |
Hospitals remain the leading end users of aortic endografts. This is attributable to increasing patient footfall, rising number of surgeries in hospitals, and availability of advanced facilities in hospital settings. The target segment is projected to expand at 4.4% CAGR during the assessment period, holding a market share of 56.0% in 2024.
Procedures for aortic endografts are frequently complicated and necessitate specialist medical facilities, which are usually found in hospitals. These facilities include hybrid operating rooms and catheterization labs. These institutions have the cutting-edge surgical and imaging equipment required for endovascular operations.
Specialized healthcare workers with training and experience in executing aortic endograft treatments, such as vascular surgeons and interventional radiologists, are typically available in hospitals. The effectiveness of these interventions depends on this knowledge.
Innovation is becoming a key focus of leading manufacturers of aortic endografts to stay ahead in this industry. They are constantly investing in research and development to introduce novel products with enhanced features like biocompatibility and durability. Partnership and collaboration are also a priority for top aortic endograft manufacturers.
Recent Developments in the Aortic Endograft Market:
| Attribute | Details |
|---|---|
| Estimated Value Market (2024) | US$ 3,430.3 million |
| Projected Aortic Stent Graft Market Size (2034) | US$ 5,513.5 million |
| Anticipated Growth Rate (2024 to 2034) | 4.9% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | United States, Japan, Europe, North America, Latin America, Asia Pacific and Middle East & Africa |
| Key Countries Covered | United States, Japan, United Kingdom, Germany, France, Italy, Spain, Russia Poland, BENELUX, Nordic Countries, Canada, Mexico, Brazil, Chile, India, ASEAN Countries, China, South Korea, Australia, New Zealand, Saudi Arabia, Israel, Other African Union, South Africa |
| Key Market Segments Covered | Product, Material, Procedure, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
The global aortic endograft market size is set to reach US$ 3,430.3 million in 2024.
Global demand is projected to increase at 4.9% CAGR through 2034.
The aortic endograft market value is expected to total US$ 5,513.5 million by 2034.
Abdominal aortic grafts segment leads the target market.
The global market increased at a 3.6% CAGR from 2018 to 2023.
The United States accounted for around 29.9% share of the global market in 2022.
Aortic endografts are mostly used to treat aneurysms.
Abdominal aorta.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value-Added Insights
4.1. Product Assessment
4.1.1. Product Adoption Analysis
4.1.2. Product USP's/Features Analysis
4.1.3. Recent Product Launches and Innovation
4.1.4. Product Matrix Analysis
4.2. Disease Epidemiology by Key Countries
4.3. Procedure Volume Analysis by Key Countries
4.4. Regulatory Scenario
4.4.1. Regulatory Frameworks in United States
4.4.2. Regulatory Frameworks in Canada
4.4.3. Regulatory Frameworks in Europe
4.4.4. Regulatory Frameworks in Brazil
4.4.5. Regulatory Frameworks in China
4.4.6. Regulatory Frameworks in Japan
4.4.7. Regulatory Frameworks in India
4.4.8. Regulatory Frameworks in Australia
4.5. Reimbursement Landscape
4.5.1. Reimbursement Guidelines
4.5.2. Reimbursement Codes
4.5.3. Payer Mix Analysis
4.6. PESTEL Analysis, By Region
4.7. Porters’ Analysis
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Life Expectancy Outlook
5.1.3. R&D funding, By Region
5.1.4. R&D funding, By Country
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Prevalence of Aortic Aneurysms
5.2.3. Diagnosis Rate (%)
5.2.4. Treatment Seeking Rate
5.2.5. Adoption for Surgery
5.2.6. Change in Pricing
5.2.7. Technology Advancement
5.2.8. Availability of Reimbursement
5.2.9. Adoption and Availability of Products
5.2.10. New Product Launches
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Volume Analysis, 2019 to 2023
6.2. Current and Future Market Volume Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Pricing Analysis, By Product Types and Price Range
7.1.1. Pricing Analysis by Region
7.1.2. Global Pricing Benchmark
7.2. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
8.1. Historical Market Value (US$ Million) Analysis, 2019 to 2023
8.2. Current and Future Market Value (US$ Million) Projections, 2024 to 2034
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Product, 2019 to 2023
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2024 to 2034
9.3.1. Abdominal Aortic Graft
9.3.2. Thoracic Aortic Graft
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Procedure
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Procedure, 2019 to 2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2024 to 2034
10.3.1. Open Surgical Repair
10.3.2. Endovascular Aneurysm Repair (EVAR)
10.3.2.1. Standard EVAR
10.3.2.2. Fenestrated EVAR
10.3.2.3. Branched EVAR
10.3.2.4. ChiMillioney EVAR
10.3.2.5. Snorkel EVAR
10.3.2.6. Hybrid EVAR
10.4. Market Attractiveness Analysis By Procedure
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Material
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Material, 2019 to 2023
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Material, 2024 to 2034
11.3.1. Metallic Endograft
11.3.1.1. Stainless Steel
11.3.1.2. Nitinol
11.3.2. Polymeric Endograft
11.3.2.1. Dacron
11.3.2.2. ePTFE
11.4. Market Attractiveness Analysis By Material
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2019 to 2023
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2024 to 2034
12.3.1. Hospitals
12.3.1.1. Private Hospitals
12.3.1.2. Public Hospitals
12.3.2. Ambulatory Surgical Centers
12.4. Market Attractiveness Analysis by End User
13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Trend Analysis by Region, 2019 to 2023
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2024 to 2034
13.3.1. United States
13.3.2. Japan
13.3.3. Europe
13.3.4. North America
13.3.5. Latin America
13.3.6. East Asia
13.3.7. Asia-Pacific
13.3.8. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. United States Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
14.3.1. By Region
14.3.1.1. Northeast
14.3.1.2. Midwest
14.3.1.3. Southeast
14.3.1.4. Southwest
14.3.1.5. West
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By Material
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Procedure
14.4.4. By Material
14.4.5. By End User
14.5. Market Trends
14.6. Drivers & Restraints Impact Analysis
14.7. Key Market Players Intensity Mapping
14.8. PESTEL Analysis
14.9. Country-Wise Analysis
14.9.1. Northeast United States Market Analysis
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Procedure
14.9.1.2.3. By Material
14.9.1.2.4. By End User
14.9.2. Midwest United States Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By Procedure
14.9.2.2.3. By Material
14.9.2.2.4. By End User
14.9.3. Southeast United States Market Analysis
14.9.3.1. Introduction
14.9.3.2. Market Analysis and Forecast by Market Taxonomy
14.9.3.2.1. By Product
14.9.3.2.2. By Procedure
14.9.3.2.3. By Material
14.9.3.2.4. By End User
14.9.4. Southwest United States Market Analysis
14.9.4.1. Introduction
14.9.4.2. Market Analysis and Forecast by Market Taxonomy
14.9.4.2.1. By Product
14.9.4.2.2. By Procedure
14.9.4.2.3. By Material
14.9.4.2.4. By End User
14.9.5. West United States Market Analysis
14.9.5.1. Introduction
14.9.5.2. Market Analysis and Forecast by Market Taxonomy
14.9.5.2.1. By Product
14.9.5.2.2. By Procedure
14.9.5.2.3. By Material
14.9.5.2.4. By End User
15. Japan Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
15.3.1. By Region
15.3.1.1. Kanto
15.3.1.2. Kansai
15.3.1.3. Chubu
15.3.1.4. Kyushu & Okinawa
15.3.1.5. Tohoku
15.3.1.6. Chugoku
15.3.1.7. Hokkaido
15.3.1.8. Shikoku
15.3.2. By Product
15.3.3. By Procedure
15.3.4. By Material
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Procedure
15.4.4. By Material
15.4.5. By End User
15.5. Market Trends
15.6. Drivers & Restraints Impact Analysis
15.7. Key Market Players Intensity Mapping
15.8. PESTEL Analysis
15.9. Country-Wise Analysis
15.9.1. Kanto Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Procedure
15.9.1.2.3. By Material
15.9.1.2.4. By End User
15.9.2. Kansai Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Procedure
15.9.2.2.3. By Material
15.9.2.2.4. By End User
15.9.3. Chubu Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Product
15.9.3.2.2. By Procedure
15.9.3.2.3. By Material
15.9.3.2.4. By End User
15.9.4. Tohoku Market Analysis
15.9.4.1. Introduction
15.9.4.2. Market Analysis and Forecast by Market Taxonomy
15.9.4.2.1. By Product
15.9.4.2.2. By Procedure
15.9.4.2.3. By Material
15.9.4.2.4. By End User
15.9.5. Kyushu & Okinawa Market Analysis
15.9.5.1. Introduction
15.9.5.2. Market Analysis and Forecast by Market Taxonomy
15.9.5.2.1. By Product
15.9.5.2.2. By Procedure
15.9.5.2.3. By Material
15.9.5.2.4. By End User
15.9.6. Chugoku Market Analysis
15.9.6.1. Introduction
15.9.6.2. Market Analysis and Forecast by Market Taxonomy
15.9.6.2.1. By Product
15.9.6.2.2. By Procedure
15.9.6.2.3. By Material
15.9.6.2.4. By End User
15.9.7. Hokkaido Market Analysis
15.9.7.1. Introduction
15.9.7.2. Market Analysis and Forecast by Market Taxonomy
15.9.7.2.1. By Product
15.9.7.2.2. By Procedure
15.9.7.2.3. By Material
15.9.7.2.4. By End User
15.9.8. Shikoku Market Analysis
15.9.8.1. Introduction
15.9.8.2. Market Analysis and Forecast by Market Taxonomy
15.9.8.2.1. By Product
15.9.8.2.2. By Procedure
15.9.8.2.3. By Material
15.9.8.2.4. By End User
16. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. Canada
16.3.1.2. Mexico
16.3.2. By Product
16.3.3. By Procedure
16.3.4. By Material
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Procedure
16.4.4. By Material
16.4.5. By End User
16.5. Market Trends
16.6. Drivers & Restraints Impact Analysis
16.7. Key Market Players Intensity Mapping
16.8. PESTEL Analysis
16.9. Country-Wise Analysis
16.9.1. Canada Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By Procedure
16.9.1.2.3. By Material
16.9.1.2.4. By End User
16.9.2. Mexico Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By Procedure
16.9.2.2.3. By Material
16.9.2.2.4. By End User
17. Latin America Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Chile
17.3.1.3. Rest of Latin America
17.3.2. By Product
17.3.3. By Procedure
17.3.4. By Material
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Procedure
17.4.4. By Material
17.4.5. By End User
17.5. Market Trends
17.6. Drivers & Restraints Impact Analysis
17.7. Key Market Players Intensity Mapping
17.8. PESTEL Analysis
17.9. Country-Wise Analysis
17.9.1. Brazil Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Product
17.9.1.2.2. By Procedure
17.9.1.2.3. By Material
17.9.1.2.4. By End User
17.9.2. Chile Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Product
17.9.2.2.2. By Procedure
17.9.2.2.3. By Material
17.9.2.2.4. By End User
18. Asia-Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
18.3.1. By Country
18.3.1.1. India
18.3.1.2. China
18.3.1.3. South Korea
18.3.1.4. ASEAN Countries
18.3.1.5. Australia
18.3.1.6. New Zealand
18.3.1.7. Rest of Asia-Pacific
18.3.2. By Product
18.3.3. By Procedure
18.3.4. By Material
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Procedure
18.4.4. By Material
18.4.5. By End User
18.5. Market Trends
18.6. Drivers & Restraints Impact Analysis
18.7. Key Market Players Intensity Mapping
18.8. PESTEL Analysis
18.9. Country-Wise Analysis
18.9.1. India Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Product
18.9.1.2.2. By Procedure
18.9.1.2.3. By Material
18.9.1.2.4. By End User
18.9.2. China Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Product
18.9.2.2.2. By Procedure
18.9.2.2.3. By Material
18.9.2.2.4. By End User
18.9.3. South Korea Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Product
18.9.3.2.2. By Procedure
18.9.3.2.3. By Material
18.9.3.2.4. By End User
18.9.4. ASEAN Countries Market Analysis
18.9.4.1. Introduction
18.9.4.2. Market Analysis and Forecast by Market Taxonomy
18.9.4.2.1. By Product
18.9.4.2.2. By Procedure
18.9.4.2.3. By Material
18.9.4.2.4. By End User
18.9.5. Australia Market Analysis
18.9.5.1. Introduction
18.9.5.2. Market Analysis and Forecast by Market Taxonomy
18.9.5.2.1. By Product
18.9.5.2.2. By Procedure
18.9.5.2.3. By Material
18.9.5.2.4. By End User
18.9.6. New Zealand Market Analysis
18.9.6.1. Introduction
18.9.6.2. Market Analysis and Forecast by Market Taxonomy
18.9.6.2.1. By Product
18.9.6.2.2. By Procedure
18.9.6.2.3. By Material
18.9.6.2.4. By End User
19. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
19.1. Introduction
19.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
19.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
19.3.1. By Country
19.3.1.1. Germany
19.3.1.2. Italy
19.3.1.3. France
19.3.1.4. United Kingdom
19.3.1.5. Spain
19.3.1.6. BENELUX
19.3.1.7. Nordic Countries
19.3.1.8. Russia
19.3.1.9. Poland
19.3.1.10. Rest of Western Europe
19.3.2. By Product
19.3.3. By Product
19.3.4. By Procedure
19.3.5. By Material
19.3.6. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Procedure
19.4.4. By Material
19.4.5. By End User
19.5. Market Trends
19.6. Drivers & Restraints Impact Analysis
19.7. Key Market Players Intensity Mapping
19.8. PESTEL Analysis
19.9. Country-Wise Analysis
19.9.1. Germany Market Analysis
19.9.1.1. Introduction
19.9.1.2. Market Analysis and Forecast by Market Taxonomy
19.9.1.2.1. By Product
19.9.1.2.2. By Procedure
19.9.1.2.3. By Material
19.9.1.2.4. By End User
19.9.2. Italy Market Analysis
19.9.2.1. Introduction
19.9.2.2. Market Analysis and Forecast by Market Taxonomy
19.9.2.2.1. By Product
19.9.2.2.2. By Procedure
19.9.2.2.3. By Material
19.9.2.2.4. By End User
19.9.3. France Market Analysis
19.9.3.1. Introduction
19.9.3.2. Market Analysis and Forecast by Market Taxonomy
19.9.3.2.1. By Product
19.9.3.2.2. By Procedure
19.9.3.2.3. By Material
19.9.3.2.4. By End User
19.9.4. United Kingdom Market Analysis
19.9.4.1. Introduction
19.9.4.2. Market Analysis and Forecast by Market Taxonomy
19.9.4.2.1. By Product
19.9.4.2.2. By Procedure
19.9.4.2.3. By Material
19.9.4.2.4. By End User
19.9.5. Spain Market Analysis
19.9.5.1. Introduction
19.9.5.2. Market Analysis and Forecast by Market Taxonomy
19.9.5.2.1. By Product
19.9.5.2.2. By Procedure
19.9.5.2.3. By Material
19.9.5.2.4. By End User
19.9.6. BENELUX Republic Market Analysis
19.9.6.1. Introduction
19.9.6.2. Market Analysis and Forecast by Market Taxonomy
19.9.6.2.1. By Product
19.9.6.2.2. By Procedure
19.9.6.2.3. By Material
19.9.6.2.4. By End User
19.9.7. Nordic Countries Market Analysis
19.9.7.1. Introduction
19.9.7.2. Market Analysis and Forecast by Market Taxonomy
19.9.7.2.1. By Product
19.9.7.2.2. By Procedure
19.9.7.2.3. By Material
19.9.7.2.4. By End User
19.9.8. Russia Market Analysis
19.9.8.1. Introduction
19.9.8.2. Market Analysis and Forecast by Market Taxonomy
19.9.8.2.1. By Product
19.9.8.2.2. By Procedure
19.9.8.2.3. By Material
19.9.8.2.4. By End User
19.9.9. Poland Market Analysis
19.9.9.1. Introduction
19.9.9.2. Market Analysis and Forecast by Market Taxonomy
19.9.9.2.1. By Product
19.9.9.2.2. By Procedure
19.9.9.2.3. By Material
19.9.9.2.4. By End User
20. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
20.1. Introduction
20.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023
20.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034
20.3.1. By Country
20.3.1.1. Saudi Arabia
20.3.1.2. Türkiye
20.3.1.3. South Africa
20.3.1.4. Other African Union
20.3.1.5. Rest of Middle East & Africa
20.3.2. By Product
20.3.3. By Procedure
20.3.4. By Material
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Procedure
20.4.4. By Material
20.4.5. By End User
20.5. Market Trends
20.6. Drivers & Restraints Impact Analysis
20.7. Key Market Players Intensity Mapping
20.8. PESTEL Analysis
20.9. Country-Wise Analysis
20.9.1. Saudi Arabia Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Product
20.9.1.2.2. By Procedure
20.9.1.2.3. By Material
20.9.1.2.4. By End User
20.9.2. Türkiye Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Product
20.9.2.2.2. By Procedure
20.9.2.2.3. By Material
20.9.2.2.4. By End User
20.9.3. South Africa Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Product
20.9.3.2.2. By Procedure
20.9.3.2.3. By Material
20.9.3.2.4. By End User
20.9.4. Other African Union Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Product
20.9.4.2.2. By Procedure
20.9.4.2.3. By Material
20.9.4.2.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players (%), 2024
21.3. Market Presence Analysis
21.3.1. Regional footprint of Players
21.3.2. Platform Type foot print by Players
21.3.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Branding and Promotional Strategies, By Key Manufactures
22.4. Key Development Analysis
22.5. Competition Deep Dive
22.5.1. Medtronic plc.
22.5.1.1. Overview
22.5.1.2. Product Portfolio
22.5.1.3. Key Financials
22.5.1.4. SWOT Analysis
22.5.1.5. Key Developments
22.5.1.6. Sales Footprint
22.5.1.7. Strategy Overview
22.5.1.7.1. Marketing Strategy
22.5.1.7.2. Product Strategy
22.5.1.7.3. Channel Strategy
22.5.2. Cook Medical
22.5.3. W. L. Gore & Associates, Inc.
22.5.4. Braile Biomédica
22.5.5. Cordis Corporation
22.5.6. Endologix LLC
22.5.7. Endospan
22.5.8. LifeTech Scientific
22.5.9. MicroPort Scientific Corporation
22.5.10. Terumo Corporation
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Aortic Endograft Market
